Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling - Zhang - 2021 - Advanced Science - Wiley Online Library
Targeting focal adhesion kinase in cancer cells and the tumor microenvironment | Experimental & Molecular Medicine
GSK2256098 | FAK Inhibitor | MedChemExpress
Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment - ScienceDirect
Summary of FAK signaling inhibitors in clinical trials. | Download Scientific Diagram
Focal Adhesion Kinase Promotes the Progression of Aortic Aneurysm by Modulating Macrophage Behavior | Arteriosclerosis, Thrombosis, and Vascular Biology
Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK) | Journal of Medicinal Chemistry
![PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/26a9977be69e5b652809520c612c75a481f39781/9-Table2-1.png "PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar")
PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar
Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment - ScienceDirect
Targeting FAK in anticancer combination therapies | Nature Reviews Cancer
Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling - Zhang - 2021 - Advanced Science - Wiley Online Library
Molecules | Free Full-Text | Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
PND-1186 (VS-4718) | ≥99%(HPLC) | Selleck | FAK inhibitor
Focal adhesion kinase—An emerging viable target in cancer and development of focal adhesion kinase inhibitors - Chauhan - 2021 - Chemical Biology & Drug Design - Wiley Online Library
Molecules | Free Full-Text | Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment - ScienceDirect
Pharmacological FAK Inhibitors. | Download Table
Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment - ScienceDirect
Pipeline | Current Clinical Trials | Verastem Oncology
Molecules | Free Full-Text | Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
PF-562271 | ≥99%(HPLC) | Selleck | FAK inhibitor
PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma | Haematologica
Targeting FAK in anticancer combination therapies | Nature Reviews Cancer
IJMS | Free Full-Text | The Crosstalk between FAK and Wnt Signaling Pathways in Cancer and Its Therapeutic Implication
The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer | Oncogenesis
Summary of clinical trials with FAK inhibitors. | Download Scientific Diagram
Targeting FAK in anticancer combination therapies | Nature Reviews Cancer
Molecules | Free Full-Text | Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
